A1C 5.6% — what it means
An HbA1c of 5.6% corresponds to an estimated average glucose of 114 mg/dL (6.3 mmol/L) and an IFCC value of 38 mmol/mol. Normal
Result summary for an A1C of 5.6%
| Measure | Value |
|---|---|
| NGSP / DCCT A1C | 5.6% |
| IFCC A1C | 38 mmol/mol |
| Estimated average glucose (eAG) | 114 mg/dL |
| eAG in mmol/L | 6.3 mmol/L |
| Category (ADA) | Normal |
| Points from 5.7% prediabetes cut point | -0.1 |
| Points from 6.5% diabetes cut point | -0.9 |
| Points from 7.0% common treatment goal | -1.4 |
| Typical average glucose spread (ADAG 95% CI, interpolated) | 90–139 mg/dL |
A normal result
An A1C of 5.6% is in the normal range. ADA defines prediabetes as 5.7% to 6.4% and diabetes as 6.5% or higher, so this result is 0.1 percentage points below the prediabetes threshold. The estimated average glucose for 5.6% is about 114 mg/dL (6.3 mmol/L).
Risk of type 2 diabetes still rises gradually across the normal range, so a value in the mid-5s does not rule out future change, especially with overweight, a family history of diabetes, a history of gestational diabetes or high blood pressure. ADA recommends screening adults from age 35, and earlier for people with risk factors, with repeat testing at least every 3 years when results are normal.
Practical next steps
- Repeat screening at least every 3 years, sooner if risk factors change.
- Keep up regular physical activity; 150 minutes a week was the target in the Diabetes Prevention Program.
- If this result came from a home kit, confirm it with an NGSP-certified lab test.
A1C values near 5.6%
Each 0.1 point of A1C equals about 2.9 mg/dL (0.16 mmol/L) of average glucose and about 1.1 mmol/mol on the IFCC scale.
| A1C | eAG mg/dL | eAG mmol/L | IFCC mmol/mol | Category |
|---|---|---|---|---|
| 4.6% | 85 | 4.7 | 27 | Normal |
| 4.7% | 88 | 4.9 | 28 | Normal |
| 4.8% | 91 | 5.0 | 29 | Normal |
| 4.9% | 94 | 5.2 | 30 | Normal |
| 5.0% | 97 | 5.4 | 31 | Normal |
| 5.1% | 100 | 5.5 | 32 | Normal |
| 5.2% | 103 | 5.7 | 33 | Normal |
| 5.3% | 105 | 5.8 | 34 | Normal |
| 5.4% | 108 | 6.0 | 35 | Normal |
| 5.5% | 111 | 6.2 | 37 | Normal |
| 5.6% | 114 | 6.3 | 38 | Normal |
| 5.7% | 117 | 6.5 | 39 | Prediabetes |
| 5.8% | 120 | 6.6 | 40 | Prediabetes |
| 5.9% | 123 | 6.8 | 41 | Prediabetes |
| 6.0% | 125 | 7.0 | 42 | Prediabetes |
| 6.1% | 128 | 7.1 | 43 | Prediabetes |
| 6.2% | 131 | 7.3 | 44 | Prediabetes |
| 6.3% | 134 | 7.4 | 45 | Prediabetes |
| 6.4% | 137 | 7.6 | 46 | Prediabetes |
| 6.5% | 140 | 7.7 | 48 | Diabetes range |
| 6.6% | 143 | 7.9 | 49 | Diabetes range |
How 5.6% compares with ADA goals
Goals differ by age, health and pregnancy. The ADA sets them individually; the figures below are the default goals in the Standards of Care.
| Group | Goal | This result |
|---|---|---|
| Most non-pregnant adults with diabetes | <7.0% | Meets goal (1.4 below) |
| Healthy older adults (few chronic illnesses, intact cognition and function) | <7.5% | Meets goal (1.9 below) |
| Older adults with complex or intermediate health | <8.0% | Meets goal (2.4 below) |
| Children and adolescents with diabetes | <7.0% | Meets goal (1.4 below) |
| Pregnancy with pre-existing diabetes | <6.0% | Meets goal (0.4 below) |
How much higher would matter
| Threshold | Increase needed | eAG at threshold |
|---|---|---|
| 5.7% | +0.1 points | 117 mg/dL |
| 6.5% | +0.9 points | 140 mg/dL |
| 7.0% | +1.4 points | 154 mg/dL |
Which weeks shaped this A1C
Hemoglobin glycation follows red blood cell turnover, so recent weeks count more. Kinetic modeling (Tahara and Shima, 1995) found that the most recent 30 days contribute about half of the A1C value. That is why a change in treatment shows up partially after one month and mostly after three.
| Period before the test | Share of A1C | Share of the 114 mg/dL average |
|---|---|---|
| Last 30 days | about 50% | 57 mg/dL weight |
| 30 to 60 days before | about 25% | 29 mg/dL weight |
| 60 to 120 days before | about 25% | 29 mg/dL weight |
When an A1C of 5.6% may not match your meter
- Iron-deficiency anemia can raise A1C; hemolysis, blood loss or a recent transfusion can lower it.
- Advanced chronic kidney disease, dialysis and erythropoietin therapy can lower it.
- Hemoglobin variants such as HbS, HbC or HbE can interfere with some assays; check that your lab method is NGSP-certified and variant-free.
- Late pregnancy lowers A1C because of faster red cell turnover.
Frequently asked questions
Is an A1C of 5.6% good?
An A1C of 5.6% is in the normal range (below 5.7%).
What average blood sugar is an A1C of 5.6%?
Using the ADAG formula eAG = 28.7 × A1C − 46.7, an A1C of 5.6% equals about 114 mg/dL, or 6.3 mmol/L.
What is 5.6% A1C in mmol/mol?
With the IFCC master equation, (5.6 − 2.152) × 10.929 gives 38 mmol/mol.
Is 5.6% A1C diabetes?
No. Diabetes is diagnosed at 6.5% or higher; 5.6% is 0.9 points below that.
How long does it take to change an A1C of 5.6%?
Because the last 30 days carry about half the weight, a sustained change in average glucose begins to show after about 4 weeks, and most of it is reflected after 8 to 12 weeks. ADA suggests retesting about every 3 months after a treatment change.
Related pages
Sources
- Nathan DM, Kuenen J, Borg R, et al. Translating the A1C assay into estimated average glucose values (ADAG Study). Diabetes Care. 2008;31(8):1473-1478.
- American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes—2026, Section 2: Diagnosis and Classification of Diabetes. Diabetes Care. 2026;49(Suppl 1).
- American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes—2026, Section 6: Glycemic Goals and Hypoglycemia. Diabetes Care. 2026;49(Suppl 1).
- American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes—2026, Section 13: Older Adults. Diabetes Care. 2026;49(Suppl 1).
- American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes—2026, Section 14: Children and Adolescents. Diabetes Care. 2026;49(Suppl 1).
- American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes—2026, Section 15: Management of Diabetes in Pregnancy. Diabetes Care. 2026;49(Suppl 1).
- Hoelzel W, Weykamp C, Jeppsson JO, et al. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes. Clin Chem. 2004;50(1):166-174. NGSP/IFCC master equation.
- Tahara Y, Shima K. Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care. 1995;18(4):440-447.
- Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.
- Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35). BMJ. 2000;321(7258):405-412.
- National Glycohemoglobin Standardization Program (NGSP). Harmonizing hemoglobin A1c testing; factors that interfere with HbA1c test results.
This page is for education and does not replace advice from your doctor. Diagnosis of diabetes requires laboratory testing and, in most cases, a repeat test.